Evaluation of an 211At-labeled RGD peptide in an orthotopic glioblastoma model by targeted alpha therapy
{{output}}
Introduction: Glioblastoma, the most aggressive and malignant glioma type, remains challenging to treat, necessitating novel therapeutic strategies. Building on our previous development of an 211At-labeled RGD peptide, Ga-DOTA-K(... ...
